Amphastar Pharmaceuticals (DE:29A)
FRANKFURT:29A
Holding DE:29A?
Track your performance easily

Amphastar Pharmaceuticals (29A) Financial Statements

0 Followers

Amphastar Pharmaceuticals Financial Overview

Amphastar Pharmaceuticals's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Amphastar Pharmaceuticals is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is €0.91. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 191.21M$ 182.39M$ 171.84M$ 178.10M$ 180.56M
Gross Profit$ 101.94M$ 95.17M$ 90.10M$ 96.14M$ 108.40M
EBIT$ 47.68M$ 50.24M$ 55.91M$ 50.80M$ 77.34M
EBITDA$ 62.86M$ 66.82M$ 72.00M$ 64.59M$ 90.91M
Net Income Common Stockholders$ 40.43M$ 37.95M$ 43.18M$ 36.17M$ 49.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 250.49M$ 217.78M$ 289.56M$ 256.81M$ 299.88M
Total Assets$ 1.55B$ 1.49B$ 1.57B$ 1.51B$ 1.54B
Total Debt$ 629.85M$ 620.58M$ 627.12M$ 623.64M$ 672.56M
Net Debt$ 379.36M$ 402.81M$ 337.56M$ 366.84M$ 372.68M
Total Liabilities$ 817.50M$ 778.18M$ 901.96M$ 873.49M$ 949.49M
Stockholders Equity$ 727.68M$ 713.35M$ 672.36M$ 639.42M$ 595.14M
Cash Flow-
Free Cash Flow$ 46.17M$ 63.06M$ 46.50M$ 14.42M$ 54.14M
Operating Cash Flow$ 59.96M$ 69.11M$ 55.29M$ 23.86M$ 64.33M
Investing Cash Flow$ -34.59M$ -69.90M$ 15.24M$ -103.05M$ -31.15M
Financing Cash Flow$ -22.82M$ -10.72M$ -13.58M$ -47.08M$ 86.61M
Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History

Amphastar Pharmaceuticals Debt to Assets

Amphastar Pharmaceuticals Cash Flow

Amphastar Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis